250. Big Pharm. The Great Big Drugs Rip-off (Part 3)

GlaxoSmithKline (GSK) In 2012, GSK agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company‚Äôs unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices. This blog is based on the press …

250. Big Pharm. The Great Big Drugs Rip-off (Part 3) Read More »